| 000 | 01742 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514234844.0 | ||
| 264 | 0 | _c20060314 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0171-5216 | ||
| 024 | 7 |
_a10.1007/s00432-005-0022-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCorte, Maria D | |
| 245 | 0 | 0 |
_aClinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). _h[electronic resource] |
| 260 |
_bJournal of cancer research and clinical oncology _cNov 2005 |
||
| 300 |
_a701-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xchemistry |
| 650 | 0 | 4 |
_aCytosol _xchemistry |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aRodil, Juan A | |
| 700 | 1 | _aVázquez, Julio | |
| 700 | 1 | _aGarcía, Lucia | |
| 700 | 1 | _aRodríguez, Juan C | |
| 700 | 1 | _aBongera, Miguel | |
| 700 | 1 | _aFernández, José C | |
| 700 | 1 | _aGonzález, Luis O | |
| 700 | 1 | _aLamelas, Ma Luz | |
| 700 | 1 | _aAllende, Maite | |
| 700 | 1 | _aGarcía-Muñiz, José L | |
| 700 | 1 | _aFueyo, Antonio | |
| 700 | 1 | _aVizoso, Francisco J | |
| 773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 131 _gno. 11 _gp. 701-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00432-005-0022-3 _zAvailable from publisher's website |
| 999 |
_c15714535 _d15714535 |
||